SV Health closes $269M dementia fund, Schrödinger cuts 60 jobs, Beckley Psytech's BPL-003 shows promise in depression, and ...

Under the program that was first announced by President Trump last week, the US would target prices based on benchmarks from ...

Cigna AI head Andy Fanning, raises $6.5M to help healthcare companies evaluate AI effectiveness through analytics software ...

Reperio Health adds telehealth to at-home testing, raises $14M led by Caduceus Capital Partners to expand services beyond ...

Biotech execs express concerns over FDA changes, NIH cuts, and Trump's tariffs. Industry confidence low amid poor funding ...

A longevity startup called Retro Biosciences is working on personalized blood disorder therapies thanks to a partnership with ...

Scientists led by David Liu and Samuel Sternberg develop improved CRISPR-based gene insertion tool called evoCAST, boosting ...

Prime Medicine announced Monday morning what it called 'breakthrough' clinical results from the first patient who received ...

Intellia's CRISPR therapy nexiguran ziclumeran maintained reductions in the levels of a misfolded protein in the nerves of ...

Regeneron is acquiring 23andMe through a court-supervised sale, following 23andMe's bankruptcy filing and recent struggles.

CellCentric raises $120M Series C for p300/CBP inhibitor inobrodib in multiple myeloma, plans Phase 2/3 trial for accelerated ...

Apnimed's oral drug met the efficacy bar in the first of two Phase 3 studies in obstructive sleep apnea, the biotech said ...